IUSSICH, Selina
 Distribuzione geografica
Continente #
NA - Nord America 5.710
EU - Europa 4.182
AS - Asia 2.070
SA - Sud America 195
AF - Africa 106
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.354
Nazione #
US - Stati Uniti d'America 5.582
IT - Italia 1.650
CN - Cina 842
IE - Irlanda 378
SG - Singapore 333
DE - Germania 329
SE - Svezia 298
FR - Francia 280
JP - Giappone 258
GB - Regno Unito 216
UA - Ucraina 195
FI - Finlandia 176
BR - Brasile 132
KR - Corea 131
PL - Polonia 126
VN - Vietnam 125
IN - India 118
AT - Austria 99
AU - Australia 82
ES - Italia 81
CA - Canada 80
SN - Senegal 73
ID - Indonesia 71
PT - Portogallo 60
TW - Taiwan 54
GR - Grecia 46
BE - Belgio 45
MX - Messico 42
NL - Olanda 38
CH - Svizzera 37
TR - Turchia 35
HK - Hong Kong 26
RU - Federazione Russa 26
CL - Cile 23
RO - Romania 23
TH - Thailandia 23
NO - Norvegia 20
CO - Colombia 13
AR - Argentina 12
HU - Ungheria 12
ZA - Sudafrica 12
UZ - Uzbekistan 10
DK - Danimarca 9
IR - Iran 9
EU - Europa 8
LT - Lituania 7
CZ - Repubblica Ceca 6
IL - Israele 6
MU - Mauritius 6
MY - Malesia 6
PE - Perù 6
PH - Filippine 6
PK - Pakistan 6
SI - Slovenia 6
UY - Uruguay 6
EG - Egitto 5
MC - Monaco 5
BG - Bulgaria 4
CU - Cuba 4
NG - Nigeria 4
SA - Arabia Saudita 4
EC - Ecuador 3
HR - Croazia 3
LV - Lettonia 3
SD - Sudan 3
AL - Albania 2
IQ - Iraq 2
KY - Cayman, isole 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
DZ - Algeria 1
GH - Ghana 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
Totale 12.354
Città #
Chandler 652
Torino 507
Fairfield 444
Beijing 392
Dublin 378
Houston 310
Ann Arbor 275
Ashburn 273
Woodbridge 240
Singapore 239
Redwood City 225
Seattle 188
Wilmington 185
Nyköping 139
Cambridge 137
Villeurbanne 137
Pisa 124
Princeton 124
Turin 124
Medford 116
Columbus 107
Dearborn 106
Warsaw 103
Jacksonville 101
Milan 94
Vienna 82
Tokyo 78
Jakarta 61
Boston 56
Guangzhou 54
Dong Ket 53
Fremont 47
Boardman 42
Nanjing 39
Taipei 36
Shanghai 35
Munich 34
Pune 33
São Paulo 30
New York 28
San Diego 27
Santa Clara 27
Athens 25
Bologna 25
Brussels 24
Buffalo 24
Ottawa 24
Helsinki 23
Camerino 22
Norwalk 22
Hefei 21
Hebei 20
Los Angeles 20
Toronto 20
Jinan 18
Utrecht 18
Perugia 17
Urbana 17
Verona 17
Padova 16
Philadelphia 16
Silver Spring 16
Wuhan 16
Columbia 15
Davis 15
Lisbon 15
London 15
Oslo 15
Rome 15
Santiago 15
Zhengzhou 15
Chongqing 14
Hangzhou 14
Sydney 14
Phoenix 13
Zurich 13
Campinas 12
Chengdu 12
Florence 12
Osaka 12
Dallas 11
Duncan 11
Kunming 11
Washington 11
Bottanuco 10
Memmingen 10
Paris 10
Seoul 10
Bangkok 9
Brisbane 9
Chennai 9
Suzhou 9
Tamworth 9
Cincinnati 8
Düsseldorf 8
Fort Collins 8
Frankfurt am Main 8
Hanover 8
Hong Kong 8
Ithaca 8
Totale 7.324
Nome #
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination 579
Pectin-honey hydrogel: Characterization, antimicrobial activity and biocompatibility 513
PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines. 369
PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis 352
The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study 330
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA 317
Chondroitin sulfate proteoglycan 4: A biomarker and potential immunotherapeutic target for canine malignant melanoma 311
FoxP3 and IDO in Canine Melanocytic Tumors 275
FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors 263
CSPG4: a prototype oncoantigen for translational immunotherapy studies 262
In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models 250
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy 236
Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations 235
A case of feline injection-site sarcoma at the site of cisplatin injections 227
Platelet-derived Growth Factors and Receptors in Canine Lymphoma 226
PDGFs/PDGFRs in canine osteosarcomas: new targets for innovative therapeutical strategies in comparative oncology 224
Activation of AKT2 in feline mammary carcinoma: a new prognostic factor in feline mammary tumors 217
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas 175
Expression of the Short Form of RON/STK in Feline Mammary Carcinoma 173
Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system. 166
Evaluation of leukocyte counts and neutrophil-to-lymphocyte ratio as predictors of local recurrence of feline injection site sarcoma after curative intent surgery 165
Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma 161
Comparison of the effects of platelet-rich plasma and plasma rich in growth factors on anastomotic healing in pigs. 160
Comparison of the effects of platelet-rich or growth factor-rich plasma on intestinal anastomosis healing in pigs 156
Transanal pull through rectal amputation for the treatment of colorectal carcinoma in 10 dogs 155
Comparison of two different barbed suture materials for end-to-end jejuno-jejunal anastomosis in pigs 154
Met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 153
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study 152
Potential Pathogenetic Role of Bovine Herpesvirus 4 in Two Dairy Cows with Dermatitis-Pyrexia-Hemorrhagic Syndrome 143
Direct intraperitoneal resuscitation with lidocaine, methylene blue and pentoxiphylline combination does not decreases inflammation after intestinal ischemia-reperfusion injury in rats 143
Direct intraperitoneal resuscitation with lidocaine, methylene blue and pentoxiphylline combination does not decreases inflammation after intestinal ischemia-reperfusion injury in rats 141
Canine oral fibrosarcoma: Changes in prognosis over the last 30 years? 141
Valutazione qualitativa della proteinuria mediante elettroforesi per pesi molecolari su gel di agarosio (SDS-AGE) ai fini della localizzazione del danno renale 135
Utility of flow cytometry in canine primary cutaneous and matched nodal mast cell tumor 130
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma 122
Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma 116
Transanal pull-through rectal amputation for the treatment of colorectal carcinoma in 11 dogs. 114
Left subclavian artery dissection associated with connective tissue abnormalities resembling Marfan-like syndrome in an English bulldog 109
Analisi istopatologica dei margini chirurgici in caso di fibrosarcoma vaccino-associato nel gatto e di mastocitoma nel cane 105
SDS-AGE proteinuria characterization and renal damage localization in dog and cat 103
Ameloblastic fibroma in Chamois (Rupicapra rupicapra). 98
Adrenal myelolipoma in a dog 97
Evaluation of the neoplastic infiltration of the skin overlying canine subcutaneous soft tissue sarcomas: An explorative study 97
Ameloblastic fibroma in an Alpine Chamois (Rupicapra rupicapra) 92
Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014) 91
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010–2020) 90
Expression of PDGFRs receptors in canine mammary carcinomas: pathological and clinical implications 89
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 88
Ameloblastic fibroma in Chamois (Rupicapra rupicapra). 83
Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland 83
Study on the stat1 expression in preoperatively doxorubicin treated feline injection-site sarcoma (FISS) 80
Fibroma ameloblastico in un Camoscio (Rupicapra rupicapra) 79
Attivazione e caratterizzazione molecolare dell’oncogene AKT nei tumori mammari felini. 75
Prevention of postoperative intraperitoneal adhesion by a Pectin-Honey Hydrogel 73
TP53 EXPRESSION AND ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPS) IN FELINE SQUAMOUS CARCINOMAS 72
Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma 72
Benign or low-grade malignant masses occupying the pelvic canal space in 11 dogs 71
Migration of a Kirschner wire to the heart in a Yorkshire terrier 70
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 70
Co-expression of PDGFR Alpha and Beta in Canine Osteosarcomas Cell Lines and Tissues: New Targets for Innovative Therapeutic Strategies. 70
Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases 67
Molecular characterization and activation of AKT oncogene in feline mammary tumors 67
Carcinoma prostatico con metastasi polmonari e miocardiche in un gatto 67
Feline vaccine-associated sarcomas: cytological results and histological correlations 67
The case of an Sry-negative XX male Pug with an inguinal gonad 65
A pectin-honey hydrogel prevents postoperative intraperitoneal adhesions in a rat model 62
Flow cytometric DNA ploidy and cell-cycle in feline vaccine-associated sarcoma 62
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma 60
Ruolo del pathway PDGFRs/PDGFs nell'osteosarcoma canino: studio di bersagli molecolari per strategie terapeutiche innovative. 60
Expression of mammalian target of rapamycin (mTOR) in feline mammary tumors: a potential target therapy in triple negative cancer 59
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 59
Expression of mammalian target of rapamycin (mTOR) in feline mammary tumors: a potential target therapy in triple negative tumors 58
Osservazioni al macello sulla patologia testicolare nei suini con particolare riferimento ai criptorchidi. 57
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines 56
Sry-negative XX sex reversal in a Pug 56
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 56
Study on the stati expression in preoperatively doxorubicin treated feline injection-site sarcoma (Fiss) 55
THE PRESENCE OF SHORT FORM OF RON/STK TRANSCRIPT COULD BE A PREDICTOR OF POOR OUTCOME IN FELINE MAMMARY CARCINOMA 55
Platelet derived growth factor receptors expression in dogs affected by malignant oral melanomas: correlation with prognosis 55
Prognostic significance of helical-CT in feline injection-site sarcoma: evaluation of eighty-two cases 54
PDGFS/PDGFRs in canine osteosarcomas: new targets for innovative therapeutical strategies in comparative oncology 54
Correlation of PDGFRs with histotype and clinical outcome in canine thyroid carcinoma 53
Evaluation of anti-prion activity of congo red and its derivatives in experimentally infected hamsters 52
Evaluation of two different barbed sutures for end-to-end jejunojejunal anastomosis in pigs. 52
Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma 51
Espressione dell’ HMW-MAA nei melanoma orali canini come potenziale target terapeutico nell’immunoterapia. 50
IMMUNOHISTOCHEMICAL EXPRESSION OF MATRIX METALLOPROTEINASE 2 (MMP-2) IN FELINE FIBROADENOMATOUS CHANGE 50
PDGFR expression is correlated to worse prognosis in dogs affected by malignant oral melanomas 50
Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene. 49
In Vivo Evaluation of a Pectin-Honey Hydrogel Coating on Polypropylene Mesh in a Rat Model of Acute Hernia 49
Use of s-100 and chromogranin a antibodies as immunohistochemical markers on detection of malignancy in aortic body tumors in dog 49
The presence of the short form of RON/STK transcript is a prognostic factor of poor outcome in feline mammary carcinomas 48
Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein 47
PCNA overexpression in bovine experimentally treated with 17 beta estradiol 47
Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer 46
Primary cutaneous undifferentiated round cell tumor with concurrent polymyositis in a dog 44
Sporadic Creutzfeldt-Jakob disease: the extent of microglia activation is dependent on the biochemical type of PrPSc. 43
IN-VITRO ESTABLISHMENT AND CHARACTERIZATION OF MYOEPITHELIAL CELL LINES FROM FOUR CANINE MAMMARY CARCINOMAS AND TWO NORMAL MAMMARY GLANDS 43
Tetracyclines affect prion infectivity 43
Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine 43
Totale 12.258
Categoria #
all - tutte 34.369
article - articoli 0
book - libri 0
conference - conferenze 8.864
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.266 0 0 0 0 94 210 212 166 185 182 103 114
2020/20211.866 130 155 145 111 159 118 110 113 212 229 142 242
2021/20221.900 153 127 133 115 109 109 124 91 138 159 332 310
2022/20232.254 215 163 73 210 224 496 190 149 214 83 126 111
2023/20241.264 141 172 77 71 102 164 68 75 8 106 107 173
2024/2025770 69 235 125 249 92 0 0 0 0 0 0 0
Totale 12.846